WST

SELL

West Pharmaceutical Services, I

Healthcare · Rank #156 · Analyzed Oct 18, 2026

$384.02

Current Price

$105.87

Intrinsic Value

-72.4%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 72.4%

Fair Value Range

Low$34.77

Base (IV)$105.87

High$143.02

Entry Points

Conservative$24.34

Moderate$34.77

Aggressive$74.11

Quality & Moat Breakdown

Return on Equity19.1% → 1.0/1.0

Debt LevelD/E 11 → 1.0/1.0

Revenue QualityGrowth 4.0%, margin Δ+3.3% → 0.5/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins17.0% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.